Sign in
PYPD Stock Price, Chart, Stats & News
PolyPid Ltd.
Save
52.28M
Market cap
–
Current P/E
–
Forward P/E
PYPD chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | -0.01% |
ROA | -153.18% |
ROE | -291.42% |
D/E | 0.25x |
Interest coverage ratio | -13.01x |
PYPD valuation
P/E | – |
P/S | – |
P/B | 8.03x |
P/CF | – |
P/FCF | – |
P/OCF | – |
PEG | -0.11x |
EV multiple | -1.45x |
About
PolyPid Ltd. is an advanced-stage biopharmaceutical company specializing in the development, manufacturing, and commercialization of therapeutic solutions. These solutions are based on its proprietary polymer-lipid encapsulation matrix (PLEX) platform, with the goal of addressing significant unmet medical needs. The company's leading product candidate, D-PLEX100, is currently undergoing Phase III clinical trials.
Similar securities
Based on sector and market capitalization
Report issue